Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00699413 · ClinicalTrials.gov registry record · Phase 4
Supplements for Controlling Resistance to Insulin
A Phase 4 study, sponsored by University of Southern California.
- Terminated
- Registry status
- Phase 4
- Development phase
- 8
- Enrollment target
NCT00699413: Clinical Trial Phase 4 study, sponsored by University of Southern California.
NCT00699413 is a Phase 4 study that was terminated before completion, run by University of Southern California. The registered enrollment target is 8 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00699413, a Phase 4 study, was terminated before completion, sponsored by University of Southern California.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effects of a combination of hydroxcycitrate (HCA) and niacin-bound chromium, in conjunction with nutrition education, over a twelve week period. Participants will be evaluated with regard to BMI, percent body fat, insulin activity, and hunger.
Primary Outcome
Change in Body Mass Index measurement at baseline and 12 weeks
Interventions
- DRUG nutrition education plus active supplement
- DRUG nutrition education plus inactive supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2008-02 |
| Est. Completion | 2008-08 |
| Phase | Phase 4 |
Why NCT00699413 stopped before completion
NCT00699413 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which nutrition education plus active supplement is the first listed.
NCT00699413 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00699413 about?
NCT00699413 is a clinical study titled "Supplements for Controlling Resistance to Insulin". The purpose of this study is to evaluate the effects of a combination of hydroxcycitrate (HCA) and niacin-bound chromium, in conjunction with nutrition education, over a twelve week period. Participants will be evaluated with regard to BMI, percent body fat, insulin activity, and hunger.
What is the current status of trial NCT00699413?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 8 participants. The study started on 2008-02. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00699413?
The interventions under investigation include: nutrition education plus active supplement (DRUG), nutrition education plus inactive supplement (DRUG).
Who is sponsoring clinical trial NCT00699413?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00699413's enrollment target sits among peer trials
8 1972nd of 2000 higher than 20 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia